Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
Titel:
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
Auteur:
Fizazi, K. Gravis, G. Flechon, A. Geoffrois, L. Chevreau, C. Laguerre, B. Delva, R. Eymard, J.C. Rolland, F. Houede, N. Laplanche, A. Burcoveanu, D. Culine, S.